GLIEMPAFLOZIN 25

GLIEMPAFLOZIN 25 contains Empagliflozin, a medicine belonging to the SGLT2 inhibitor class, used primarily in the management of Type 2 Diabetes Mellitus as part of a broader treatment plan that includes diet and exercise. It is often prescribed either as an add-on to existing anti-diabetic therapy or, in select cases, as part of initial treatment, depending on a physician's overall assessment of the patient's condition.

Empagliflozin works by targeting the SGLT2 protein in the kidneys, which is normally responsible for reabsorbing glucose from the urine back into the bloodstream. By blocking this reabsorption process, Empagliflozin allows excess glucose to be excreted directly through urine instead of being returned to circulation. Because this mechanism operates independently of insulin, it remains effective even in patients whose pancreatic insulin production has declined — a common feature of long-standing Type 2 diabetes.

What distinguishes Empagliflozin from many other diabetes medicines is the growing body of clinical evidence supporting benefits that extend beyond blood sugar control. In patients with Type 2 diabetes who also have established cardiovascular disease or are at high cardiovascular risk, Empagliflozin has been associated with reduced risk of certain cardiovascular events. It has also shown kidney-protective effects in patients with diabetic kidney disease, helping to slow the progression of kidney function decline in appropriate candidates. This dual role — as both a glucose-lowering agent and a medicine with organ-protective potential — has made SGLT2 inhibitors like Empagliflozin an increasingly important part of modern Type 2 diabetes management.

Product Information

Why GLIEMPAFLOZIN 25 Is Important

Type 2 diabetes rarely exists in isolation — many patients living with the condition also face elevated cardiovascular risk and a gradual decline in kidney function over time, both of which are among the leading causes of illness and mortality in people with diabetes. Managing blood sugar alone, without considering these broader risks, often falls short of what modern diabetes care aims to achieve.

GLIEMPAFLOZIN 25 is clinically important because it:

• Provides effective insulin-independent blood sugar control, useful regardless of how much natural insulin production remains
• Offers documented cardiovascular risk-reduction benefits in patients with Type 2 diabetes and existing cardiovascular disease, based on clinical study evidence
• Shows kidney-protective effects in patients with diabetic kidney disease, helping support long-term kidney health
• Provides modest, favorable effects on body weight and blood pressure, both relevant considerations in comprehensive diabetes management
• Fits well into combination therapy, working alongside other anti-diabetic medicines like Metformin or DPP-4 inhibitors for patients who need multi-mechanism control

Because Empagliflozin's benefits extend into cardiovascular and kidney health — areas of major long-term concern for people with diabetes — GLIEMPAFLOZIN 25 represents more than symptom management; it reflects a broader strategy to reduce the serious downstream complications diabetes can cause.

Key Benefits

• Insulin-independent glucose lowering, effective even as natural insulin production declines
• Supports cardiovascular risk reduction in patients with Type 2 diabetes and existing heart disease, based on clinical evidence
• Offers kidney-protective benefits, helping slow progression in patients with diabetic kidney disease
• Modest positive effects on body weight and blood pressure
• Works effectively as monotherapy or in combination with other anti-diabetic medicines
• Once-daily dosing supports convenient, consistent treatment adherence
• Backed by WHO-GMP certified manufacturing, ensuring consistent tablet quality

Precautions

• Should be used only under medical supervision, with regular monitoring of blood glucose, HbA1c, and kidney function
• Caution advised in patients with significant kidney impairment, as effectiveness and safety depend on adequate kidney function
• Increases urinary glucose excretion, which can raise the risk of genital and urinary tract infections — good hygiene and prompt reporting of symptoms is advised
• Risk of dehydration or low blood pressure, particularly in elderly patients or those on diuretics
• Rare risk of diabetic ketoacidosis has been reported with SGLT2 inhibitors, even with normal or mildly elevated blood sugar — any unusual nausea, vomiting, abdominal pain, or unusual fatigue should be reported promptly
• Temporary discontinuation may be advised before major surgery or during periods of significant fluid loss (illness, vomiting, reduced fluid intake) — consult the prescribing physician
• Not recommended during pregnancy or breastfeeding unless specifically advised by a physician
• Elderly patients should be monitored closely for dehydration and blood pressure changes
• Inform the doctor of all other medications, as certain diuretics and blood pressure medicines may interact with this treatment

Side Effects

• Genital or urinary tract infections
• Increased urination
• Dizziness, particularly if dehydration occurs
• Thirst
• Constipation
• Mild rash in sensitive individuals
• Rarely: diabetic ketoacidosis, even with normal blood sugar levels — requires immediate medical attention
• Rarely: significant drop in blood pressure, especially in elderly or volume-depleted patients

Frequently Asked Questions

1. Where can I buy Empagliflozin 25 mg online?
You can buy Empagliflozin 25 mg through licensed online pharmacies or authorized pharmaceutical suppliers in India. Verify the manufacturer, strength, batch number and expiry date before purchasing.

2. What is the price of Empagliflozin 25 mg?
The price may vary depending on the brand, manufacturer, pack size, seller and applicable charges. Check the current price with a licensed pharmacy or authorized supplier.

3. Can I order Empagliflozin 25 mg online?
Yes, Empagliflozin 25 mg can be ordered online through licensed pharmacies or authorized suppliers where legally available. A valid prescription may be required.

4. Is Empagliflozin 25 mg available from Steris Healthcare?
Availability depends on Steris Healthcare's current product range and stock status. Contact Steris Healthcare or an authorized distributor to confirm the strength, pack size and ordering details.

5. What is Empagliflozin 25 mg used for?
Empagliflozin 25 mg is used to help control blood sugar in adults with type 2 diabetes. Depending on the approved indication, empagliflozin may also be used for certain heart failure or chronic kidney disease conditions.

6. What is the composition of Empagliflozin 25 mg?
Empagliflozin 25 mg contains Empagliflozin 25 mg as the active pharmaceutical ingredient. Other inactive ingredients may vary depending on the specific product formulation.

7. Is a prescription required for Empagliflozin 25 mg?
Empagliflozin 25 mg is generally used under medical supervision, and a prescription may be required. Follow applicable local requirements and your healthcare professional's advice.

8. How should Empagliflozin 25 mg be taken?
Take Empagliflozin 25 mg exactly as prescribed by your doctor. It is taken orally and may generally be taken with or without food. Swallow the tablet with water and do not change the dose without medical advice.

9. What should I know before buying Empagliflozin 25 mg?
Before buying, verify the exact strength, manufacturer, batch number, expiry date, packaging and storage instructions. Inform your doctor about kidney problems, dehydration, low blood pressure, pregnancy, breastfeeding or other medicines you take.

10. How can I order Empagliflozin 25 mg online?
To order Empagliflozin 25 mg online, choose a licensed pharmacy or authorized supplier, select the prescribed strength and pack size, provide a prescription if required, and verify the product details before completing the purchase.